Gildas is the Chief Investment Officer at Windrose Advisors, bringing over twenty years of experience to the investment process. Gildas oversees investment strategy, asset allocation and manager selection for the firm. He is a member of the Windrose Advisors Investment Committee.

Previously, Gildas served as the Deputy Chief Investment Officer at Partners HealthCare System, a Boston hospital group including leading academic medical centers affiliated with Harvard Medical School. Over the course of his tenure with the Investment Office, assets under management grew from $3 billion to over $13 billion, and his prior responsibilities expanded from analyst to portfolio manager and director of public markets. In his various roles, Gildas managed a money market portfolio of up to $1 billion, evaluated, and selected managers across all asset classes, including public and private alternatives, and participated in the Investment Committee of Partners HealthCare.

Gildas earned a dual MBA degree from the D’Amore McKim School of Business at Northeastern University and NEOMA Business School in France. He holds both the Chartered Financial Analyst® and the Chartered Alternative Investment Analyst® designations. He was honored in 2014 with a “Rising Star” award by Investor Intelligence Network and has been a guest speaker at Boston College, New York University and Northeastern University. He currently serves on the Investment Committee of the Longwood Collective, a non-profit organization dedicated to enhancing Boston’s Longwood Medical and Academic area. Gildas is a member of the Finance and Audit Committees of the Waring School, an independent private school in Beverly, Massachusetts.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CAIA® is a registered certification mark owned and administered by the Chartered Alternative Investment Analyst Association.